TrialDiabetes technology & therapeutics2017

Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.

Bruce W Bode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.